Filibuvir

DB11878InvestigationalSmall molecule

Filibuvir has been used in trials studying the treatment of Hepatitis, Hepatitis C, and Chronic Hepatitis C.

Chemical structure of Filibuvir
Mechanism
Curator reviewed
Formula / weight
C29H37N5O3 · 503.6358 g/mol (avg)
Code names
PF-00868554 · PF-868554

Resolves to

Compound
UNII198J479Y2LCAS877130-28-4ChEMBLCHEMBL490672PubChem54708673
Structure
InChIKeySLVAPEZTBDBAPI-GDLZYMKVSA-NSMILESCCC1=CC(CC[C@@]2(CC(O)=C(CC3=NN4C(=N3)N=C(C)C=C4C)C(=O)O2)C2CCCC2)=CC(CC)=N1
Targets
O39930NS5bP26664Genome polyprotein

What you can answer from here — as of June 15, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
8Clinical trialsPhase, status and sponsor resolved per trial
Sign in
5+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Filibuvir, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In